557 related articles for article (PubMed ID: 24398326)
21. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
[TBL] [Abstract][Full Text] [Related]
22. Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.
Oschlies I; Kohler CW; Szczepanowski M; Koch K; Gontarewicz A; Metze D; Hillen U; Richter J; Spang R; Klapper W
J Invest Dermatol; 2017 Nov; 137(11):2450-2453. PubMed ID: 28684330
[No Abstract] [Full Text] [Related]
23. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.
Xu-Monette ZY; Zhang H; Zhu F; Tzankov A; Bhagat G; Visco C; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; You H; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Hagemeister FB; Shahbaba B; De Dios I; Zhang H; Li Y; Xu B; Albitar M; Young KH
Blood Adv; 2020 Jul; 4(14):3391-3404. PubMed ID: 32722783
[TBL] [Abstract][Full Text] [Related]
24. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
Hwang HS; Yoon DH; Hong JY; Park CS; Lee YS; Ko YH; Kim SJ; Kim WS; Suh C; Huh J
Ann Hematol; 2018 Dec; 97(12):2363-2372. PubMed ID: 30069703
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Mottok A; Wright G; Rosenwald A; Ott G; Ramsower C; Campo E; Braziel RM; Delabie J; Weisenburger DD; Song JY; Chan WC; Cook JR; Fu K; Greiner T; Smeland E; Holte H; Savage KJ; Glinsmann-Gibson BJ; Gascoyne RD; Staudt LM; Jaffe ES; Connors JM; Scott DW; Steidl C; Rimsza LM
Blood; 2018 Nov; 132(22):2401-2405. PubMed ID: 30257882
[TBL] [Abstract][Full Text] [Related]
26. Genetic profiling of
Ennishi D; Mottok A; Ben-Neriah S; Shulha HP; Farinha P; Chan FC; Meissner B; Boyle M; Hother C; Kridel R; Lai D; Saberi S; Bashashati A; Shah SP; Morin RD; Marra MA; Savage KJ; Sehn LH; Steidl C; Connors JM; Gascoyne RD; Scott DW
Blood; 2017 May; 129(20):2760-2770. PubMed ID: 28351934
[TBL] [Abstract][Full Text] [Related]
27. Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue.
Green TM; de Stricker K; Møller MB
Diagn Mol Pathol; 2009 Dec; 18(4):243-9. PubMed ID: 19861891
[TBL] [Abstract][Full Text] [Related]
28. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
29. A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.
Bosch M; Akhter A; Chen BE; Mansoor A; Lebrun D; Good D; Crump M; Shepherd L; Scott DW; Stewart DA
Haematologica; 2018 Feb; 103(2):288-296. PubMed ID: 29097500
[TBL] [Abstract][Full Text] [Related]
30. QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma.
Hall JS; Usher S; Byers RJ; Higgins RC; Memon D; Radford JA; Linton KM
J Mol Diagn; 2015 Jul; 17(4):402-11. PubMed ID: 25982535
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay.
Kim SJ; Sohn I; Do IG; Jung SH; Ko YH; Yoo HY; Paik S; Kim WS
Ann Hematol; 2014 Mar; 93(3):437-47. PubMed ID: 23975159
[TBL] [Abstract][Full Text] [Related]
33. Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Abdulla M; Hollander P; Pandzic T; Mansouri L; Ednersson SB; Andersson PO; Hultdin M; Fors M; Erlanson M; Degerman S; Petersen HM; Asmar F; Grønbaek K; Enblad G; Cavelier L; Rosenquist R; Amini RM
Am J Hematol; 2020 Jan; 95(1):57-67. PubMed ID: 31659781
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.
Foot NJ; Dunn RG; Geoghegan H; Wilkins BS; Neat MJ
J Clin Pathol; 2011 Sep; 64(9):802-8. PubMed ID: 21593346
[TBL] [Abstract][Full Text] [Related]
35. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
36. Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.
Collie AM; Nölling J; Divakar KM; Lin JJ; Carver P; Durkin LM; Hill BT; Smith MR; Radivoyevitch T; Kong LI; Daly T; Murugesan G; Guenther-Johnson J; Dave SS; Manilich EA; Hsi ED
Br J Haematol; 2014 Oct; 167(2):281-5. PubMed ID: 24961756
[No Abstract] [Full Text] [Related]
37. Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance.
Ahmed S; Glover P; Taylor J; Sha C; Care MA; Tooze R; Davies A; Westhead DR; Johnson PWM; Burton C; Barrans SL
Br J Haematol; 2021 Feb; 192(3):599-604. PubMed ID: 33249557
[TBL] [Abstract][Full Text] [Related]
38. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
Rimsza LM; Leblanc ML; Unger JM; Miller TP; Grogan TM; Persky DO; Martel RR; Sabalos CM; Seligmann B; Braziel RM; Campo E; Rosenwald A; Connors JM; Sehn LH; Johnson N; Gascoyne RD
Blood; 2008 Oct; 112(8):3425-33. PubMed ID: 18544678
[TBL] [Abstract][Full Text] [Related]
39. Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining.
Reinke S; Richter J; Fend F; Feller A; Hansmann ML; Hüttl K; Oschlies I; Ott G; Möller P; Rosenwald A; Stein H; Altenbuchinger M; Spang R; Klapper W
Virchows Arch; 2018 Sep; 473(3):341-349. PubMed ID: 29730836
[TBL] [Abstract][Full Text] [Related]
40. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.
Barrans SL; Crouch S; Care MA; Worrillow L; Smith A; Patmore R; Westhead DR; Tooze R; Roman E; Jack AS
Br J Haematol; 2012 Nov; 159(4):441-53. PubMed ID: 22970711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
